Atherectomy Devices Market Size & Growth Analysis to 2030

Key Findings:

• The market size was valued at ~ US$ 1 billion in 2023 and experiencing a significant growth rate of ~ 8% by 2030
• By type, the directional atherectomy systems segment dominated the market in 2023 with the largest market of over 1/3 market
• Geographically, North America is accounted to hold the largest market share in the benchmark year 2023

The global atherectomy devices market size was valued at around USD 1 billion in 2023 and anticipated grow at a significant CAGR of around 8% during the forecast period from 2024 to 2030. The driving factors of the market are primarily centered on the rising prevalence of cardiovascular diseases, particularly atherosclerosis, which is a major cause of morbidity and mortality worldwide. The growing aging population, coupled with lifestyle factors such as poor diet, lack of exercise, and increased rates of obesity and diabetes, has led to a higher incidence of arterial blockages. This has fueled the demand for minimally invasive procedures like atherectomy, which offers advantages over traditional treatments by reducing recovery times and improving patient outcomes. Additionally, technological advancements in atherectomy devices, such as laser-based and directional atherectomy systems, have made procedures safer and more effective, further boosting market growth. Moreover, there is an estimated increase in peripheral artery disease (PAD) prevalence of more than 17%, adding to the rising need for atherectomy devices.

Another key factor driving market expansion is the increased awareness and diagnostic capabilities for PAD. In 2019 alone, 113 million people worldwide lived with PAD, with 10 million new cases and 74,063 related deaths, highlighting the urgency for effective treatments. With healthcare systems placing greater emphasis on early detection and intervention, the use of atherectomy devices has become more widespread. Furthermore, the growing adoption of advanced imaging techniques to guide atherectomy procedures has improved treatment precision. Government initiatives aimed at reducing the burden of cardiovascular diseases, coupled with increased healthcare spending, particularly in emerging markets, are also contributing to the market’s growth.

Market Snapshot:

To know more about the research report, request sample papers

Market Trends:

Shift toward minimally invasive procedures: There is a growing preference for minimally invasive treatments in managing cardiovascular and peripheral artery diseases. Patients and healthcare providers favor atherectomy devices for their ability to remove arterial plaque with less trauma compared to traditional surgical methods. These procedures often lead to quicker recovery times, reduced hospital stays, and fewer post-operative complications, making them a popular choice.

Increased use in ambulatory surgical centers (ASCs): The adoption of atherectomy procedures in outpatient settings such as ambulatory surgical centers is on the rise. ASCs offer more cost-effective alternatives to traditional hospital-based treatments, allowing patients to receive care in a more convenient setting. The trend toward outpatient treatments is fueled by the desire for reduced healthcare costs, shorter recovery periods, and efficient use of healthcare resources.

Advancement in atherectomy technologies: Continuous technological advancements have significantly improved the efficacy and safety of atherectomy devices. Innovations in laser, directional, rotational, and orbital atherectomy systems have led to more precise plaque removal, minimizing the risk of damage to surrounding tissues. These developments are driving the adoption of atherectomy devices, as they provide better clinical outcomes in treating complex arterial blockages.

Integration with advanced imaging systems: Atherectomy devices are increasingly being used in conjunction with advanced imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT). These imaging systems allow physicians to visualize the inside of arteries with greater accuracy, enabling them to assess blockages and guide the atherectomy procedure more effectively. This integration leads to improved precision, better patient outcomes, and reduced risks during interventions.

Product innovation and R&D investment: Leading market players are heavily investing in research and development to introduce innovative atherectomy devices. The focus is on expanding product portfolios to address a wide range of conditions, including complex coronary and peripheral artery diseases. These innovations aim to improve the efficiency of plaque removal while reducing procedure time and patient discomfort, driving increased adoption in clinical practice.

Market Opportunities:

The global atherectomy devices market presents significant opportunities, particularly due to the rising prevalence of cardiovascular and peripheral artery diseases (PAD) globally. As the aging population grows and lifestyle diseases such as diabetes and obesity increase, the demand for effective treatment options will continue to expand. This creates an opportunity for manufacturers to develop and introduce advanced atherectomy devices that cater to complex cases with minimal invasiveness. Emerging markets, particularly in regions like Asia-Pacific and Latin America, where healthcare infrastructure is improving and the burden of cardiovascular diseases is rising, offer vast potential for market expansion. Companies can tap into these regions by offering affordable and innovative solutions that meet the growing healthcare needs.

Another key opportunity lies in the increasing integration of atherectomy devices with digital health technologies. The adoption of advanced imaging systems, artificial intelligence (AI), and machine learning in guiding atherectomy procedures can improve precision, reduce complications, and optimize patient outcomes. Furthermore, the trend toward outpatient care, driven by cost-saving initiatives and healthcare reform, opens the door for atherectomy devices to be more widely used in ambulatory surgical centers (ASCs). As governments and regulatory bodies support minimally invasive treatments and early detection of PAD, there is an opportunity for companies to secure regulatory approvals for new devices, further accelerating market growth.

Market Restraints:

The global atherectomy devices market faces several restraining factors, primarily the high cost of devices and procedures, which can limit accessibility, particularly in developing regions. Additionally, reimbursement challenges in certain healthcare systems can reduce the affordability of atherectomy treatments, impacting adoption rates. The complexity of the procedures requires skilled professionals, and a shortage of trained specialists in some areas can further hinder market growth. Moreover, there are potential risks and complications associated with atherectomy procedures, such as arterial damage or restenosis, which may cause healthcare providers to opt for alternative treatments, posing another barrier to the market’s expansion.

Market Insights:

The global atherectomy devices market is bifurcated into type, application, end-user, and geography. On the basis of type, the directional atherectomy systems segment dominated the market in 2023 with the largest revenue share of over 1/3 market. These systems are widely adopted due to their ability to precisely remove large amounts of plaque from arterial walls while minimizing damage to healthy tissues. Their versatility in treating peripheral arteries, particularly in the legs and arms, makes them highly effective for managing conditions like peripheral artery disease (PAD). Directional atherectomy systems are favored for their accuracy in plaque debulking, enabling physicians to address complex blockages that may not be suitable for other methods. This has led to their broad use in hospitals and ambulatory surgical centers, driving their market dominance.

Additionally, the growing prevalence of PAD, especially among aging populations and individuals with diabetes, has further accelerated the demand for directional atherectomy systems. Their effectiveness in removing both soft and calcified plaque makes them a preferred option for healthcare providers. The continued advancements in these systems, including better guidewire compatibility and improved plaque capture technology, have enhanced their efficacy and safety. This combination of precision, versatility, and technological advancements ensures that directional atherectomy systems maintain their leadership position in the market.

Market Trends for Directional Atherectomy Systems Sub-category:

• Increasing demand for minimally invasive procedures: There is a significant shift in patient and healthcare provider preferences toward minimally invasive treatment options, particularly in managing peripheral artery disease (PAD). These procedures, such as those utilizing directional atherectomy systems, offer benefits like reduced recovery times, decreased postoperative complications, and the ability to perform interventions with less trauma to the body. This growing demand is propelling the adoption of directional atherectomy systems as an effective solution for plaque removal.
• Integration with advanced imaging technologies: The incorporation of advanced imaging technologies, such as intravascular ultrasound (IVUS), has become a prominent trend in the use of directional atherectomy systems. These imaging tools provide real-time visualization of arterial blockages, allowing healthcare providers to make more informed decisions during procedures. Enhanced imaging capabilities improve the accuracy and effectiveness of directional atherectomy, leading to better patient outcomes and increased procedural success rates.

Opportunities for Directional Atherectomy Systems Sub-category:

• Growth in emerging markets: Emerging markets, particularly in regions like Asia-Pacific and Latin America, present significant growth opportunities for directional atherectomy systems. The rising incidence of peripheral artery disease, driven by increasing rates of diabetes, obesity, and cardiovascular conditions, creates a heightened demand for effective treatment solutions. As healthcare infrastructure continues to develop in these regions, there is a favorable environment for the adoption of innovative medical technologies like directional atherectomy systems.
• Expanding healthcare infrastructure: Improvements in healthcare systems in emerging markets, coupled with a growing awareness of the importance of treating peripheral artery disease, facilitate the acceptance and use of directional atherectomy systems. As healthcare providers become more educated about the benefits of these systems, the likelihood of adoption increases, driving market growth. This trend emphasizes the importance of tailored marketing and education efforts to inform both healthcare professionals and patients about the advantages of directional atherectomy.

The atherectomy devices market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.

Historical & Forecast Period

• 2020-22 – Historical Year
• 2023 – Base Year
• 2024-2030 – Forecast Period

Market Segmentation:

By Type:

• Directional Atherectomy Systems
• Orbital Atherectomy Systems
• Photo-Ablative (Laser) Atherectomy Systems
• Rotational Atherectomy Systems

By Application:

• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

By End-User:

• Hospitals and Surgical Centers
• Ambulatory Care Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

Geographically, the North America region is the dominant market for atherectomy devices, primarily driven by advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and significant investments in medical technology. The United States, in particular, accounts for a substantial share of the market due to its well-established healthcare system, high rates of coronary artery disease, and increasing cases of peripheral artery disease (PAD). The presence of key market players, along with continuous innovations in atherectomy devices, further solidifies North America’s leadership position. Additionally, strong government initiatives and favorable reimbursement policies for minimally invasive procedures contribute to the widespread adoption of atherectomy technologies in this region.

Another factor contributing to North America’s dominance in the atherectomy devices market is the high level of awareness and acceptance of advanced medical treatments among healthcare providers and patients. The region has a large number of specialized cardiovascular and vascular centers, where atherectomy procedures are performed frequently. The integration of advanced imaging techniques and minimally invasive surgical options enhances the efficacy of these devices, making them a preferred choice in clinical practice. As healthcare providers increasingly recognize the benefits of atherectomy procedures in improving patient outcomes, the demand for these devices continues to rise, further strengthening North America’s position as the leading region in the atherectomy devices market.

Competitive Landscape:

Some of the leading market players operating in the global atherectomy devices market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Cordis Corporation (a Cardinal Health company), and B. Braun Melsungen AG. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Cordis Corporation (a Cardinal Health company)
• Braun Melsungen AG
• Cook Medical
• Johnson & Johnson (Ethicon)
• Spectranetics (a part of Royal Philips)
• Cardiovascular Systems, Inc. (CSI)
• Terumo Corporation

Key Questions Answered by Atherectomy Devices Market Report

• Global atherectomy devices market forecasts from 2024-2030
• Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
• Atherectomy devices submarket forecasts from 2024-2030 covering the market by type, application, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level atherectomy devices markets from 2024-2030
• Competitive Landscape and market positioning of top 10 players operating in the market